Mounjaro Complications: Making a Fully Informed Decision

Which complications are genuinely common, and which are rare?

The complications most people encounter with Mounjaro sit in the digestive system. Nausea is the leader (reported by a significant proportion of participants in clinical trials) followed by vomiting, diarrhoea, constipation, indigestion, burping and fatigue. Most of these are tied to how GLP-1 medications like tirzepatide work: by slowing the movement of food through the stomach, the body needs time to recalibrate. For the majority of people, these effects are most pronounced in the first week or two after starting or stepping up a dose, then settle considerably. Staying well-hydrated and eating smaller, lower-fat meals during that window helps most people through it.

Less common but worth knowing: injection-site reactions (redness, mild swelling) can occur at the abdomen, thigh or upper arm. Some people notice dizziness or headaches, particularly early in treatment. Hair thinning, reported more broadly with rapid weight loss regardless of method, occasionally comes up too, it is usually temporary.

Serious complications are infrequent. Acute pancreatitis is the one the MHRA's Yellow Card scheme most actively monitors: on 29 January 2026 the MHRA issued a Drug Safety Update highlighting pancreatitis as a known, if uncommon, risk with GLP-1 medicines. If you develop severe, persistent pain in your upper abdomen that spreads to your back (with or without vomiting) stop eating and seek urgent medical attention. Gallbladder problems (including gallstones and inflammation) are also in the risk picture; pain in the upper right abdomen, fever or jaundice are the signals to act on.

Allergic reactions are rare but possible. Signs include swelling of the face, lips or throat, or difficulty breathing. These need emergency care.

The complications that depend heavily on your individual health picture

Some complications of Mounjaro are not universal, they depend on what else is going on in your health history. This is the core reason the prescriber review matters, and it is the part that a quick price comparison cannot replicate.

People with a personal or family history of medullary thyroid carcinoma, or with Multiple Endocrine Neoplasia syndrome type 2 (MEN2), should not use tirzepatide, the SmPC is clear on this, and a thorough assessment of medical indications before starting is the safeguard.

A history of pancreatitis, significant gastroparesis, or inflammatory bowel disease means extra scrutiny rather than an automatic no, your prescriber weighs frequency, severity and current status. Similarly, if you take medicines whose absorption timing matters, the gastric-emptying effect of tirzepatide can alter how they work, and you can read about how Mounjaro interacts with other medications if that is relevant to your situation. The interaction question comes up regularly, and there is detailed guidance covering Mounjaro medication interactions worth reading if you are on regular prescriptions.

For women using oral contraceptives, a specific precaution applies: MHRA and NHS guidance advises adding a non-oral method of contraception for the first four weeks of treatment and for four weeks after every dose increase, because the pill's absorption can be reduced during that window. This is not a complication in the traditional sense, but it is a real clinical risk if overlooked. Your prescriber will flag it; do not wait to be asked.

Kidney function is worth noting too. Severe dehydration from prolonged vomiting or diarrhoea can strain the kidneys, particularly in people who already have reduced kidney function. Drinking enough fluid during any GI flare matters more than it might otherwise.

Surgery, pregnancy and other situations where complications escalate

If you are planning a surgical procedure, tell the anaesthetist and the surgical team that you take tirzepatide. The slowed gastric emptying means there is a higher risk of regurgitation under general anaesthetic; guidance from NHS England advises healthcare teams to be informed well in advance. The timing of when to pause treatment before surgery is a conversation for your prescriber, it is not something to decide alone based on a forum post.

Mounjaro is not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive. Women of childbearing age should use effective contraception throughout treatment and, on current guidance, for a period after stopping, your prescriber will confirm the appropriate wash-out window. Under-18s are outside the licensed population entirely.

For anyone considering what tirzepatide actually involves day to day: it is a once-weekly subcutaneous injection, self-administered via a pre-filled pen. The pen itself is straightforward to use, and a full guide to the Mounjaro application process covers exactly how to use it. The NHS tirzepatide medicine page carries the official patient-level overview of side effects and what to do if they occur, and it is worth bookmarking.

At nume, every clinical review happens before each repeat order, not just at the start. If a complication arises between orders, our aftercare team is available seven days a week, and the prescriber, not a chatbot, reviews the picture. You can read more about how our clinical model works and the team behind it, including our lead prescriber.

Deciding whether to start treatment is a clinical conversation, not a solo calculation. If you want to explore whether Mounjaro is appropriate for your circumstances, a free consultation is the right first step, the prescriber works through your health history, current medications and any risk factors before anything else happens. When treatment does proceed and is dispensed from our GPhC-registered pharmacy, it arrives the next working day in plain, unbranded packaging via DPD, with tracking sent to your phone. That part is simple. The clinical bit is where care lives.

You can also read about the cost of Mounjaro treatment in the UK if that is part of your thinking, or explore the full range of weight-loss treatments to compare your options with a prescriber's help.